Swedbank’s OptimizeRx OPRX Stock Holding History

Swedbank’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-79,960	Closed	-$2.19M	–	754
2022 Q2	$2.19M	Buy	79,960 +20,000	+33%	+$593K	﹤0.01%	592
2022 Q1	$2.26M	Hold	59,960	–	–	﹤0.01%	615
2021 Q4	$3.67M	Sell	59,960 -5,000	-8%	-$379K	0.01%	593
2021 Q3	$5.56M	Sell	64,960 -15,000	-19%	-$941K	0.01%	534
2021 Q2	$4.95M	Sell	79,960 -5,000	-6%	-$254K	0.01%	552
2021 Q1	$4.14M	Buy	+84,960	New	+$4.1M	0.01%	567

Other funds holding OPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Swedbank's OPRX Position: Q3 2022 in Review

Swedbank sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 79,960 shares — an estimated $2.19M sold.

Swedbank first reported a position in OPRX in Q1 2021 and held it in 6 quarters. The position peaked at $5.56M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

Swedbank reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
Swedbank sold 79,960 OptimizeRx shares in Q3 2022, an estimated $2.19M.
Swedbank first reported a position in OptimizeRx in Q1 2021 and held it in 6 quarters.
Swedbank's OptimizeRx position peaked at $5.56M in Q3 2021.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Swedbank's 13F filing for Q3 2022, filed 6 Dec 2024.